Cancer can affect anyone, anywhere. As a way to promote research for curing as well as preventing the disease, World Cancer Day is both a celebration of the progress we’ve made so far, and a call to do more to reduce cancer-related deaths worldwide. And cancer immunotherapy can one day help us reach our goal.
As the only nonprofit in the world dedicated exclusively to funding cancer immunology and immunotherapy research, the Cancer Research Institute (CRI) has had a strong global impact on how cancer is being treated. Since it was established in 1953, CRI has invested more than $311 million in research worldwide aimed at understanding the immune response to cancer and developing new therapies to harness the immune system to treat and—one day—cure all cancers. Of this, nearly $55 million has been invested internationally across six continents. A few of these grants include:
- More than $6.9 million to Australia, including $1.35 million for graduate student training in cancer immunology and nearly $2.2 million for clinical trials as part of our coordinated global clinical trials network
- Almost $5.6 million in support of research and clinical trials in Japan
- More than $12.6 million to Switzerland
- Nearly $1.3 million to Russia
- More than $1 million to Israel
We have also invested in Argentina, Cameroon, Canada, China, France, Greece, Italy, Korea, Malaysia, Spain, Sweden, The Netherlands, and United Kingdom. In all, we have funded 19 non-U.S. countries!
Watch this video of our scientists from around the world as they say the word “cure” in their native language—from Bengali to Ukrainian—and help us get there sooner by making a donation today.
You can also get involved in World Cancer Day and show your support for global awareness for cancer research by joining in the "Talking Hands" activity, and sharing your photos with us on Twitter @CancerResearch, using both the hashtags #WorldCancerDay and #WeCanICan.